Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Attenuation of the self-renewal of transit-amplifying osteoblast progenitors in the murine bone marrow by 17β-estradiol
Gina B. Di Gregorio, Matsuo Yamamoto, A. Afshan Ali, Etsuko Abe, Paula Roberson, Stavros C. Manolagas, Robert L. Jilka
Gina B. Di Gregorio, Matsuo Yamamoto, A. Afshan Ali, Etsuko Abe, Paula Roberson, Stavros C. Manolagas, Robert L. Jilka
View: Text | PDF
Article

Attenuation of the self-renewal of transit-amplifying osteoblast progenitors in the murine bone marrow by 17β-estradiol

  • Text
  • PDF
Abstract

In agreement with evidence that estrogens slow the rate of bone remodeling by suppressing the production of both osteoclasts and osteoblasts, loss of estrogens leads to an increase in the number of osteoclast as well as early osteoblast progenitors (CFU-osteoblasts; CFU-OBs) in the murine bone marrow. Here we show that CFU-OBs are early transit-amplifying progenitors, i.e., dividing cells capable of limited self-renewal, and that 17β-estradiol acts in vivo and in vitro to attenuate their self-renewal by approximately 50%. Consistent with a direct receptor–mediated action of estrogens on early mesenchymal cell progenitors, anti–estrogen receptor-α (anti-ERα) Ab’s stain a small number of marrow cells that exhibit characteristics of primitive undifferentiated cells, including a high nucleus/cytoplasm ratio and lack of lineage-specific biochemical markers; the effect of 17β-estradiol on CFU-OB self-renewal is absent in mice lacking ERα. Because both osteoblasts and the stromal/osteoblastic cells that are required for osteoclast development are derived from CFU-OBs, suppression of the self-renewal of this common progenitor may represent a key mechanism of the anti-remodeling effects of estrogens.

Authors

Gina B. Di Gregorio, Matsuo Yamamoto, A. Afshan Ali, Etsuko Abe, Paula Roberson, Stavros C. Manolagas, Robert L. Jilka

×

Figure 6

Options: View larger image (or click on image) Download as PowerPoint
The role of the ER in the suppressive effect of 17β-estradiol on CFU-OB ...
The role of the ER in the suppressive effect of 17β-estradiol on CFU-OB self-renewal. (a) ICI 182,780 blocks the effect of 17β-estradiol. Marrow cell cultures were established in collagen gels (7.5 × 106 per gel) in the absence or presence of 50 nM ICI 182,780. The cultures were maintained for 6 days without (Veh) or with 1 nM 17β-estradiol and then assayed for CFU-OB number. Assay of freshly isolated cells indicated that there were 281 ± 17 CFU-OBs per 7.5 × 106 cells used to establish each culture. Thus, there was a 5.4-fold increase in CFU-OBs in cultures maintained in vehicle in the absence of ICI 182,780. Bars represent the mean number (± SEM) of CFU-OBs per gel. AP < 0.05 treatment versus vehicle as determined by mixed-effects ANOVA. (b) Lack of effect of 17β-estradiol on CFU-OBs from ERα–/– mice. Marrow cells were obtained from ERα+/+ or ERα–/– mice, and collagen gel cultures were established using 8 × 106 cells per gel. Cultures were maintained in the absence or presence of 10 nM 17β-estradiol for 5 days and then assayed for CFU-OBs. Assay of freshly isolated cells from ERα+/+ or ERα–/– mice indicated that there were 248 ± 56 or 384 ± 56 CFU-OBs, respectively, per 8 × 106 cells used to establish each culture. Thus, there was a 7.3-fold (ERα+/+) or 6.5-fold (ERα–/–) increase in CFU-OBs in cultures maintained in vehicle. Bars represent the mean number (± SEM) of progenitors. AP < 0.05 treatment versus vehicle as determined by mixed-effects ANOVA.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts